id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-N-0318-0006,FDA,FDA-2004-N-0318,"Transcript of November 18, 2004 Stakeholder Meeting",Other,Transcript(s),2004-12-29T05:00:00Z,2004,12,,,2025-09-26T17:48:39Z,,0,0,090000648047300c
FDA-2004-N-0318-0003,FDA,FDA-2004-N-0318,"Transcript of November 18, 2004 Stakeholder Meeting",Other,Transcript(s),2004-12-29T05:00:00Z,2004,12,,,2025-09-26T17:47:25Z,,0,0,0900006480473009
FDA-2004-N-0318-0004,FDA,FDA-2004-N-0318,"Transcript of November 18, 2004 Stakeholder Meeting",Other,Transcript(s),2004-12-29T05:00:00Z,2004,12,,,2025-09-26T17:47:41Z,,0,0,090000648047300a
FDA-2004-P-0401-0001,FDA,FDA-2004-P-0401,"Acknowledgment Letter from FDA/CDER to Andrx Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-29T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-28T01:00:45Z,,0,0,09000064804744d0
FDA-2004-P-0401-0002,FDA,FDA-2004-P-0401,"Acknowledgment Letter from FDA/CDER to Andrx Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-29T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T21:26:48Z,,0,0,09000064804744d6
FDA-2004-N-0318-0002,FDA,FDA-2004-N-0318,"Transcript of November 18, 2004 Stakeholder Meeting",Other,Transcript(s),2004-12-29T05:00:00Z,2004,12,,,2025-09-26T17:47:08Z,,0,0,0900006480473008
FDA-2004-N-0318-0005,FDA,FDA-2004-N-0318,"Transcript of November 18, 2004 Stakeholder Meeting",Other,Transcript(s),2004-12-29T05:00:00Z,2004,12,,,2025-09-26T17:48:17Z,,0,0,090000648047300b
FDA-2004-N-0318-0011,FDA,FDA-2004-N-0318,MDUFMA and the GMP Inspection Program,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T16:56:03Z,,0,0,0900006480473015
FDA-2004-N-0318-0012,FDA,FDA-2004-N-0318,BIMO and MDUFMA,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T16:59:49Z,,0,0,0900006480473016
FDA-2004-N-0318-0015,FDA,FDA-2004-N-0318,Inspection by Accredited persons (AP) Program,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T17:15:34Z,,0,0,0900006480473019
FDA-2004-N-0318-0014,FDA,FDA-2004-N-0318,CBER and MDUFMA Quantitative Goals,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T17:11:01Z,,0,0,0900006480473018
FDA-2004-N-0318-0009,FDA,FDA-2004-N-0318,Premarket Review Performance Goals,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T18:51:39Z,,0,0,0900006480473011
FDA-2004-N-0318-0013,FDA,FDA-2004-N-0318,Modular PMA Updates,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T17:07:48Z,,0,0,0900006480473017
FDA-2004-N-0318-0007,FDA,FDA-2004-N-0318,"Agenda for November 18, 2004 Meeting",Other,List (LST),2004-12-29T00:00:00Z,2004,12,,,2025-04-30T16:39:05Z,,0,0,090000648047300d
FDA-2004-N-0318-0010,FDA,FDA-2004-N-0318,CBER MDUFMA Activity,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T18:52:55Z,,0,0,0900006480473012
FDA-2004-N-0318-0016,FDA,FDA-2004-N-0318,Reuse of Single Use Devices,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T17:18:33Z,,0,0,090000648047301b
FDA-2004-N-0318-0008,FDA,FDA-2004-N-0318,Financial Aspects of MDUFMA,Other,Testimony,2004-12-29T00:00:00Z,2004,12,,,2025-04-30T18:50:19Z,,0,0,090000648047300e
FDA-1980-N-0049-0088,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:41:00Z,,0,0,09000064805b99f4
FDA-1980-N-0049-0091,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:51:32Z,,0,0,09000064805b99f7
FDA-1980-N-0049-0089,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:44:51Z,,0,0,09000064805b99f5
FDA-2004-P-0345-0002,FDA,FDA-2004-P-0345,"Acknowledgment Letter from FDA DMB to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2004-12-27T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T20:51:13Z,,0,0,09000064804734a7
FDA-2004-P-0096-0002,FDA,FDA-2004-P-0096,"Acknowledgment Letter from FDA/DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-27T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T19:34:05Z,,0,0,090000648046f4ed
FDA-2004-P-0363-0001,FDA,FDA-2004-P-0363,"Acknowledgment Letter from FDA/DMB to Methapharm, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-27T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T21:01:11Z,,0,0,090000648047364f
FDA-1980-N-0049-0087,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:27:53Z,,0,0,09000064805b99f3
FDA-1980-N-0049-0092,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:56:57Z,,0,0,09000064805b99f8
FDA-1980-N-0049-0090,FDA,FDA-1980-N-0049,Panel Report on Bacterial Vaccines and Toxoids; Implementation of Efficacy Review,Other,Report,2004-12-27T05:00:00Z,2004,12,,,2020-05-21T12:47:47Z,,0,0,09000064805b99f6
FDA-2004-P-0345-0001,FDA,FDA-2004-P-0345,"Acknowledgment Letter from FDA/DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-27T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T20:38:11Z,,0,0,09000064804734a2
FDA-2004-P-0096-0001,FDA,FDA-2004-P-0096,"Acknowledgment Letter from FDA/DMB to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-27T05:00:00Z,2004,12,2004-12-27T05:00:00Z,,2025-03-27T19:29:18Z,,0,0,090000648046f4e6
FDA-2004-D-0122-0002,FDA,FDA-2004-D-0122,Compliance Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2004-12-23T05:00:00Z,2004,12,,,2013-08-11T04:06:32Z,,0,0,090000648046fbbe
FDA-2004-P-0338-0001,FDA,FDA-2004-P-0338,HFA-305 to Valeant Pharmaceuticals International,Other,ACK-Acknowledgement Letter,2004-12-22T05:00:00Z,2004,12,,,2008-04-12T00:49:25Z,,0,0,09000064804732f6
FDA-2004-P-0338-0002,FDA,FDA-2004-P-0338,HFA-305 to Valeant Pharmaceuticals International,Other,ACK-Acknowledgement Letter,2004-12-22T05:00:00Z,2004,12,,,2008-04-12T00:49:25Z,,0,0,09000064804732ff
FDA-2004-S-0442-0003,FDA,FDA-2004-S-0442,"Agenda for November 8, 2004 meeting",Other,LST-List,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:54Z,,0,0,0900006480474a96
FDA-2004-V-0030-0002,FDA,FDA-2004-V-0030,HFA-305 to Varian Medical Systems,Other,ACK-Acknowledgement Letter,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:58Z,,0,0,090000648046a954
FDA-2004-S-0442-0006,FDA,FDA-2004-S-0442,"Attendees to November 8, 2004 meeting",Other,LST-List,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:54Z,,0,0,0900006480474a99
FDA-2004-V-0362-0002,FDA,FDA-2004-V-0362,HFA-305 to G and G Sound and Lighting,Other,ACK-Acknowledgement Letter,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:53:37Z,,0,0,0900006480473647
FDA-2004-S-0442-0004,FDA,FDA-2004-S-0442,"Agenda for November 8, 2004 meeting",Other,LST-List,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:55Z,,0,0,0900006480474a97
FDA-2004-V-0030-0001,FDA,FDA-2004-V-0030,HFA-305 to Varian Medical Systems,Other,ACK-Acknowledgement Letter,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:58Z,,0,0,090000648046a950
FDA-2004-S-0442-0007,FDA,FDA-2004-S-0442,"Transcript the November 8, 2004 meeting",Other,TR-Transcript,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:54Z,,0,0,0900006480474a9a
FDA-2004-P-0472-0003,FDA,FDA-2004-P-0472,"HFD-005 to Winston Laboratories, Inc.",Other,LET-Letter,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:50:23Z,,0,0,0900006480475c8d
FDA-2004-S-0442-0005,FDA,FDA-2004-S-0442,"Agenda for November 8, 2004 meeting",Other,LST-List,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:52:55Z,,0,0,0900006480474a98
FDA-2004-V-0362-0001,FDA,FDA-2004-V-0362,HFA-305 to G and G Sound and Lighting,Other,ACK-Acknowledgement Letter,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:53:37Z,,0,0,0900006480473643
FDA-2003-H-0215-0044,FDA,FDA-2003-H-0215,HFA-305,Other,CS-Certificate of Service,2004-12-17T05:00:00Z,2004,12,,,2008-04-12T00:57:12Z,,0,0,090000648048c767
FDA-2000-N-0109-0127,FDA,FDA-2000-N-0109,Exhibit B-294: Reserved,Other,Exhibit(s),2004-12-16T05:00:00Z,2004,12,,,2026-02-17T19:24:19Z,,0,0,09000064804cd9b1
FDA-2003-H-0215-0040,FDA,FDA-2003-H-0215,HF-3,Other,OR-Order,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:57:11Z,,0,0,090000648048c75e
FDA-2004-V-0032-0001,FDA,FDA-2004-V-0032,HFA-305 to Mezzanotte LLC,Other,ACK-Acknowledgement Letter,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:52:59Z,,0,0,090000648046a963
FDA-2003-H-0215-0041,FDA,FDA-2003-H-0215,HFA-305 to Henry E. Schwartz LLC,Other,CS-Certificate of Service,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:57:13Z,,0,0,090000648048c760
FDA-2004-V-0031-0001,FDA,FDA-2004-V-0031,HFA-305 t0 Tinsletown 17,Other,ACK-Acknowledgement Letter,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:52:59Z,,0,0,090000648046a95b
FDA-2004-P-0176-0001,FDA,FDA-2004-P-0176,Acknowledgement Letter from FDA/DMB to Arent Fox,Other,Acknowledgement Letter/Receipt,2004-12-15T05:00:00Z,2004,12,2004-12-15T05:00:00Z,,2025-03-26T21:57:46Z,,0,0,09000064804701a9
FDA-2003-H-0215-0039,FDA,FDA-2003-H-0215,GCF-1,Other,RMO-Reply to Motion,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:57:12Z,,0,0,090000648048c75b
FDA-2004-V-0238-0003,FDA,FDA-2004-V-0238,HFZ-300 to Jake Barner Studios,Other,VRA-Approval for Variance,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:53:25Z,,0,0,09000064804718d2
FDA-2004-V-0296-0004,FDA,FDA-2004-V-0296,HFA-300 to Hot Wax Unlimited,Other,VRA-Approval for Variance,2004-12-15T05:00:00Z,2004,12,,,2008-04-12T00:53:30Z,,0,0,0900006480472d00
FDA-2004-P-0018-0002,FDA,FDA-2004-P-0018,Letter from FDA CFSAN to Environmental Working Group,Other,Letter(s),2004-12-15T05:00:00Z,2004,12,2004-12-14T05:00:00Z,,2025-02-11T21:39:27Z,,0,0,090000648046a8b2
FDA-2004-P-0018-0001,FDA,FDA-2004-P-0018,Letter from FDA CFSAN to Environmental Working Group,Other,Letter(s),2004-12-15T05:00:00Z,2004,12,2004-12-14T05:00:00Z,,2025-02-12T02:00:43Z,,0,0,090000648046a8a6
FDA-1993-V-0011-0001,FDA,FDA-1993-V-0011,"Kozmic Lazer Show, LLP - Approval for Variance",Other,VRA-Approval for Variance,2004-12-13T05:00:00Z,2004,12,,,2008-11-06T14:53:19Z,,0,0,09000064804fa256
FDA-2004-P-0474-0003,FDA,FDA-2004-P-0474,FDA/CDER to King & Spalding LLP,Other,LET-Letter,2004-12-13T05:00:00Z,2004,12,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce2
FDA-2004-P-0418-0002,FDA,FDA-2004-P-0418,"Acknowledgment Letter from FDA/DMB to Olsson, Frank and Weeda, P.C.",Other,Acknowledgement Letter/Receipt,2004-12-10T05:00:00Z,2004,12,2004-12-10T05:00:00Z,,2025-03-26T21:05:28Z,,0,0,0900006480474614
FDA-2004-P-0418-0001,FDA,FDA-2004-P-0418,"Acknowledgment Letter from FDA/DMB to Olsson, Frank and Weeda, P.C.",Other,Acknowledgement Letter/Receipt,2004-12-10T05:00:00Z,2004,12,2004-12-10T05:00:00Z,,2025-03-26T21:03:10Z,,0,0,090000648047460e
FDA-2004-P-0343-0003,FDA,FDA-2004-P-0343,"Acknowledgment Letter from FDA/DMB to MGP Ingredients, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-09T05:00:00Z,2004,12,2004-12-09T05:00:00Z,,2025-03-26T20:46:32Z,,0,0,090000648047346a
FDA-2003-H-0215-0038,FDA,FDA-2003-H-0215,HFA-305 to Henry E. Schwartz LLC,Other,CS-Certificate of Service,2004-12-09T05:00:00Z,2004,12,,,2008-04-12T00:57:13Z,,0,0,090000648048c759
FDA-2004-P-0343-0002,FDA,FDA-2004-P-0343,"Acknowledgment Letter from FDA/DMB to MGP Ingredients, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-09T05:00:00Z,2004,12,2004-12-09T05:00:00Z,,2025-03-26T20:44:55Z,,0,0,0900006480473468
FDA-2003-H-0215-0037,FDA,FDA-2003-H-0215,HF-3,Other,OR-Order,2004-12-09T05:00:00Z,2004,12,,,2008-04-12T00:57:12Z,,0,0,090000648048c757
FDA-2004-P-0343-0001,FDA,FDA-2004-P-0343,"Acknowledgment Letter from FDA/DMB to MGP Ingredients, Inc.",Other,Acknowledgement Letter/Receipt,2004-12-09T05:00:00Z,2004,12,2004-12-09T05:00:00Z,,2025-03-26T20:42:22Z,,0,0,0900006480473464
FDA-2004-P-0282-0002,FDA,FDA-2004-P-0282,"Citizen Petition Approval from FDA CDER to Lachman Consultant Services, Inc.",Other,Approval,2004-12-08T05:00:00Z,2004,12,2004-11-23T05:00:00Z,,2025-01-07T22:58:45Z,,0,0,09000064804726dd
FDA-2001-P-0003-0002,FDA,FDA-2001-P-0003,"HFD-7 to Rothwell, Figg, Ernst & Manbeck, PC (Mylan Pharmaceuticals Inc)",Other,CR-Correction,2004-12-08T05:00:00Z,2004,12,,,2024-09-10T19:33:13Z,,0,0,09000064804b3dc7
FDA-2004-N-0569-0014,FDA,FDA-2004-N-0569,"List of participants, attendees",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:45:32Z,,0,0,090000648048332b
FDA-2004-N-0569-0006,FDA,FDA-2004-N-0569,"Transcript of November 15, 2004 Public Meeting",Other,TR-Transcript,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:45:55Z,,0,0,090000648048330b
FDA-2004-N-0569-0012,FDA,FDA-2004-N-0569,"Director, Division of Dietary Supplement Programs, FDA",Other,TS-Testimony,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:44:31Z,,0,0,0900006480483311
FDA-2004-N-0569-0011,FDA,FDA-2004-N-0569,"Director, Division of Dietary Supplement Programs, FDA",Other,TS-Testimony,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:46:18Z,,0,0,0900006480483310
FDA-2004-N-0569-0015,FDA,FDA-2004-N-0569,"List of participants, attendees",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:45:32Z,,0,0,090000648048332c
FDA-2004-N-0569-0016,FDA,FDA-2004-N-0569,"List of participants, attendees",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:45:32Z,,0,0,090000648048332d
FDA-2004-N-0569-0007,FDA,FDA-2004-N-0569,"Transcript of November 15, 2004 Public Meeting",Other,TR-Transcript,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:46:18Z,,0,0,090000648048330c
FDA-1994-P-0041-0248,FDA,FDA-1994-P-0041,HFA-305 to International Dairy Foods Association,Other,ACK-Acknowledgement Letter,2004-12-08T05:00:00Z,2004,12,,,2008-05-16T23:20:44Z,,0,0,09000064804ff076
FDA-2004-N-0569-0008,FDA,FDA-2004-N-0569,"Transcript of November 15, 2004 Public Meeting",Other,TR-Transcript,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:45:11Z,,0,0,090000648048330d
FDA-2004-N-0569-0009,FDA,FDA-2004-N-0569,"Agenda for November 15, 2004 meeting",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:43:40Z,,0,0,090000648048330e
FDA-2004-N-0569-0010,FDA,FDA-2004-N-0569,"Agenda for November 15, 2004 meeting",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:44:51Z,,0,0,090000648048330f
FDA-1994-P-0041-0247,FDA,FDA-1994-P-0041,HFA-305 to International Dairy Foods Association,Other,ACK-Acknowledgement Letter,2004-12-08T05:00:00Z,2004,12,,,2008-05-16T23:20:54Z,,0,0,09000064804ff075
FDA-2004-N-0569-0013,FDA,FDA-2004-N-0569,"List of participants, attendees",Other,LST-List,2004-12-08T05:00:00Z,2004,12,,,2008-04-12T00:44:11Z,,0,0,090000648048332a
FDA-2004-P-0409-0003,FDA,FDA-2004-P-0409,"Citizen Petition Approval from FDA CDER to Lachman Consultant Services, Inc`",Other,Approval,2004-12-08T05:00:00Z,2004,12,2004-11-23T05:00:00Z,,2025-02-13T19:34:13Z,,0,0,090000648047458b
FDA-1997-S-0006-0099,FDA,FDA-1997-S-0006,"HFS-800 to EuroPharma, Inc",Other,LET-Letter,2004-12-07T05:00:00Z,2004,12,,,2008-05-16T22:06:53Z,,0,0,09000064805c98d9
FDA-1997-S-0006-0098,FDA,FDA-1997-S-0006,"HFS-800 to Tianshi Health Products, Inc",Other,LET-Letter,2004-12-07T05:00:00Z,2004,12,,,2008-05-16T22:07:06Z,,0,0,09000064805c98d8
FDA-1997-S-0006-0100,FDA,FDA-1997-S-0006,HFS-800 to Leiner Health Products,Other,LET-Letter,2004-12-07T05:00:00Z,2004,12,,,2008-05-16T22:07:02Z,,0,0,09000064805c98da
FDA-2004-P-0465-0001,FDA,FDA-2004-P-0465,Acknowledgment Letter from FDA/DMB to London and Mead,Other,Acknowledgement Letter/Receipt,2004-12-07T05:00:00Z,2004,12,2004-12-07T05:00:00Z,,2025-03-26T01:00:39Z,,0,0,0900006480475877
FDA-2004-P-0465-0002,FDA,FDA-2004-P-0465,Acknowledgment Letter from FDA/DMB to London and Mead,Other,Acknowledgement Letter/Receipt,2004-12-07T05:00:00Z,2004,12,2004-12-07T05:00:00Z,,2025-03-25T22:10:49Z,,0,0,09000064804758a1
FDA-2003-P-0015-0005,FDA,FDA-2003-P-0015,"Petition Denial from FDA CDER  to Jerussi Consulting, Inc.",Other,PDN-Petition Denial,2004-12-06T05:00:00Z,2004,12,2004-12-02T05:00:00Z,,2024-11-04T19:28:37Z,,0,0,0900006480481346
FDA-2003-P-0348-0003,FDA,FDA-2003-P-0348,"Petition Approval from FDA CDER to Lachman Consultant Services, Inc.",Other,PAV-Petition Approval,2004-12-06T05:00:00Z,2004,12,2004-11-23T05:00:00Z,,2024-11-06T21:51:14Z,,0,0,0900006480497058
FDA-2004-Q-0427-0003,FDA,FDA-2004-Q-0427,"FDA Response to Fleminger, Inc - Letter",Other,ANS-Answer,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:51:34Z,,0,0,0900006480474806
FDA-2004-V-0232-0002,FDA,FDA-2004-V-0232,Acknowledgement Letter to Tribal Existance Productions,Other,ACK-Acknowledgement Letter,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:49:44Z,,0,0,0900006480471883
FDA-2004-P-0149-0003,FDA,FDA-2004-P-0149,Letter from FDA CDER to Abbott Laboratories,Other,Letter(s),2004-12-06T05:00:00Z,2004,12,2004-11-30T05:00:00Z,,2024-12-23T22:19:43Z,,0,0,090000648046ff09
FDA-2004-V-0232-0001,FDA,FDA-2004-V-0232,Acknowledgement Letter to Tribal Existance Productions,Other,ACK-Acknowledgement Letter,2004-12-06T05:00:00Z,2004,12,,,2013-07-27T20:49:44Z,,0,0,0900006480471880
FDA-2004-Q-0427-0004,FDA,FDA-2004-Q-0427,FDA Response to Mr. and Mrs. Richard James - Comment,Other,,2004-12-06T00:00:00Z,2004,12,,,2013-08-11T04:07:04Z,,0,1,0900006480474807
FDA-2004-V-0166-0001,FDA,FDA-2004-V-0166,FDA/DDM to Forum Developers Limited Partnership,Other,ACK-Acknowledgement Letter,2004-12-03T05:00:00Z,2004,12,,,2008-04-12T00:53:08Z,,0,0,0900006480470104
FDA-2004-V-0166-0002,FDA,FDA-2004-V-0166,FDA/DDM to Forum Developers Limited Partnership,Other,ACK-Acknowledgement Letter,2004-12-03T05:00:00Z,2004,12,,,2008-04-12T00:53:08Z,,0,0,0900006480470109
FDA-1994-P-0023-0002,FDA,FDA-1994-P-0023,Citizen Petition Denial from FDA CDRH to MiniMed Technologies,Other,Denial of Petition,2004-12-03T05:00:00Z,2004,12,,,2024-07-29T17:37:19Z,,0,0,09000064804fd1a4
FDA-2004-P-0275-0033,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:46Z,,0,0,09000064804725ab
FDA-2004-P-0275-0015,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:39Z,,0,0,0900006480472599
FDA-2004-P-0275-0012,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:39Z,,0,0,0900006480472596
FDA-2004-P-0275-0016,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:50Z,,0,0,090000648047259a
FDA-2004-P-0275-0022,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:45Z,,0,0,09000064804725a0
FDA-2004-P-0275-0031,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:43Z,,0,0,09000064804725a9
FDA-2004-P-0275-0026,FDA,FDA-2004-P-0275,HF-22,Other,LET-Letter,2004-12-02T05:00:00Z,2004,12,,,2008-04-12T00:48:45Z,,0,0,09000064804725a4